Valeant Teams With Bill Ackman to Buy Allergan

April 23 (Bloomberg) -- Valeant offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Stephanie Ruhle reports on Bill Ackman’s involvement on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)

IG's Pan Says Economic Growth Picking Up in Asia
06:50 - Jingyi Pan, market strategist at IG Asia, discusses Asian bank earnings and non-performing loans. She speaks on "Bloomberg Markets: Asia." (Source: Bloomberg)
  • Earnings Up at Chinese Oil Companies
  • China Construction Bank 1Q Profit Rises
  • Full Show: What'd You Miss? (04/27)